You are here: Industry Insights > IL-6

News List

Research Progress on Pharmacological Effects and Mechanism of Asiaticoside PharmaSources/Xiao Michong
January 04, 2022
Asiaticoside is one of the main components of triterpenoid saponins, which is the centella asiatica extract, and its molecular formula is C48H78O19.
Tang Prize Laureates Reflect on the Breakthroughs Made Possible by Cytokine Research prnasia
November 29, 2021
Following the inspiring opening speech, "Future Perspective of Cancer Immunotherapy," delivered by Nobel Prize and Tang Prize laureate Prof. Tasuku Honjo at the 14th Asia Pacific Federation of Pharmacologist Conference (APFP) ...
Ortho Clinical Diagnostics Announces Launch of the Interleukin-6 (IL-6) Reagent Pack, Latest Addition to Ortho's Critical Care Blood Testing Menu prnasia
July 23, 2021
Ortho Clinical Diagnostics announced its VITROS® Immunodiagnostic Products IL-6 Reagent Pack, the latest addition to Ortho's VITROS® Critical Care menu, is now available in EU Countries, U.K. and several ASPAC and LATAM countries.*
IL-6 antagonists reduce risk of death in hospitalised COVID-19 patients, finds analysis europeanpharmaceuticalreview
July 08, 2021
WHO recommends IL-6 antagonists plus corticosteroids for hospitalised COVID-19 patients based on their ability to reduce risk of death and the need for mechanical ventilation.
Algernon to drop Phase III trial of Ifenprodil for Covid-19 pharmaceutical-technology
July 07, 2021
Algernon Pharmaceuticals has plans not to progress the development of its drug candidate, Ifenprodil, into a Phase III clinical trial for Covid-19.
Algernon’s Ifenprodil lowers interleukin 6 in Phase IIb/III Covid-19 trial pharmaceutical-technology
May 13, 2021
Algernon Pharmaceuticals has reported that NP-120 (Ifenprodil) statistical significantly lowered interleukin 6 (IL-6) in its Phase IIb/III trial to treat Covid-19.
Zydus’ Desidustat efficacious in treating hypoxia in Mexico’s hospitalised COVID-19 patients: Study expresspharma
January 25, 2021
None of the hospitalised patients required mechanical ventilator in the Desidustat arm, while 25 per cent patients on the standard of care arm required mechanical ventilator.
MBio Delivers Rapid Cytokine Test System for COVID-19 Research prnewswire
June 16, 2020
Rapid Point-of-Care Test for Interleukin-6 (IL-6) to be used in Clinical Studies.
IL-6 Level May Predict Symptom Duration in Concussed Athletes drugs
July 04, 2019
IL-6 Level May Predict Symptom Duration in Concussed Athletes.